Business
MedX Health Appoints Dr. Symon Cotton as Strategic Advisor on AI & Product Development
MedX Health Corp. (TSXV: MDX), (“ MedX ” or the “ Company ”),...
About this update from Medx Health Corp.
[{"type":"text","content":"MedX Health Appoints Dr. Symon Cotton as Strategic Advisor on AI & Product Development\n\n\n .bwalignc { text-align: center; list-style-position: inside }\n \n\n\n\n MedX Health Corp. (TSXV: MDX), (“\n \n MedX\n \n ” or the “\n \n Company\n \n ”), a global leader in teledermatology and non-invasive skin analysis, today announced the appointment of\n \n Dr. Symon D. Cotton\n \n , accomplished medical device innovator and co-developer of SIAscopy®, as Strategic Advisor to the Company.\n \n\n Dr. Cotton is an experienced author and leader in medical technology innovation, currently serving as Head of Life Sciences at a leading technology organization. His career has been defined by work at the intersection of engineering, biology and computation, where he has successfully guided numerous companies through the development of novel medical devices and digital health platforms.\n \n\n As one of the key scientific architects of\n \n Spectrophotometric Intracutaneous Analysis (SIAscopy®)\n \n , Dr. Cotton collaborated with Dr. Paul Matts in its early development and codification. Together, they helped establish SIAscopy as the world’s first technology to enable the\n \n simultaneous, non-invasive measurement of melanin, hemoglobin and collagen\n \n within the skin. Their work provided the foundation for SIAscopy’s clinical adoption in dermatology and its integration into MedX’s DermSecure® platform.\n \n\n Beyond his foundational contributions, Dr. Cotton’s expertise extends to applying\n \n AI-driven analytics to medical imaging and diagnostics\n \n , a skill set directly aligned with MedX’s strategic roadmap. His leadership in computational biology, device design, and translational medicine equips MedX to further enhance its AI models trained on SIAscopy’s uniquely rich imaging datasets, driving greater diagnostic accuracy and scalability.\n \n\n “I am proud to have been part of the original SIAscopy journey and excited to rejoin the field with MedX at such a pivotal moment,” said Dr. Cotton. “With AI poised to transform teledermatology, I look forward to helping MedX leverage its unmatched imaging database and DermSecure® platform to improve early skin cancer detection worldwide.”\n \n\n John Gevisser, CEO of MedX Hea...